期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 65, 期 1, 页码 -出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01422-20
关键词
tuberculosis; diabetes; metformin; host-directed
资金
- National Health and Medical Research Council (NHMRC) through a CJ Martin Biomedical Early Career Fellowship [APP1052764, APP1140709, APP1120808]
- Australian Institute of Tropical Health and Medicine (AITHM) Capacity Building Grant [15031]
- AITHM scholarship
There is a difference in the efficacy of MET against tuberculosis in diabetic and nondiabetic individuals, which warrants further investigation.
Comorbid type 2 diabetes poses a great challenge to the global control of tuberculosis. Here, we assessed the efficacy of metformin (MET), an antidiabetic drug, in mice infected with a very low dose of Mycobacterium tuberculosis. In contrast to diabetic mice, infected nondiabetic mice that received the same therapeutic concentration of MET presented with significantly higher disease burden. This warrants further studies to investigate the disparate efficacy of MET against tuberculosis in diabetic and nondiabetic individuals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据